Search

Call the Presidential candidates to account for science and make sure they recognise scientific issues are global, says world-leading biologist and Nobel laureate David Baltimore.

Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.

Nuclear power is back in favour – but does Europe have the skills and resources to bring the industry into the 21st century?

The move from the warm embrace of global healthcare giant GE to a tiny biotech start-up was an exhilarating experience for Bill Clarke.

The European Commission wants member states to adopt a code of conduct for nanotechnology research at universities, research institutes and companies.

Ten European research institutions and a UK biotech company are joining forces to study the memory loss in Alzheimer’s and to develop treatments.

Tough news for America. China’s technological development is set to make it the main driver of world’s economy – and an integrated Europe could overtake it too.